Chronic treatment with imipramine and lithium increases cell proliferation in the hippocampus in adrenocorticotropic hormone-treated rats

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 1, 2011, Pages 77-81

  Kitamura, Yoshihisa ^a   Doi, Maho ^a   Kuwatsuka, Keiko ^a   Onoue, Yuka ^a   Miyazaki, Ikuko ^a   Shinomiya, Kazuaki ^a   Koyama, Toshihiro ^a   Sendo, Toshiaki ^b   Kawasaki, Hiromu ^a   Asanuma, Masato ^a   Gomita, Yutaka ^c  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c SHUJITSU UNIVERSITY   (Japan)

Author keywords

5 bromo 2 deoxyyridine; Adrenocorticotropic hormone; Cell proliferation; Imipramine; Lithium

Indexed keywords

CORTICOTROPIN; IMIPRAMINE; LITHIUM CARBONATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; RAT; SUBGRANULAR ZONE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; CELL PROLIFERATION; HIPPOCAMPUS; IMIPRAMINE; LITHIUM; MALE; NEUROGENESIS; NEURONS; RATS; RATS, WISTAR;

EID: 78951483264     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.77     Document Type: Article

References (29)

1. Kessler R. C., Berglund P., Demler O., Jin R., Koretz R., Merikangas K. R., Rush A. J., Walters E. E., Wang P. S., J. Am. Med. Assoc., 289, 3095-3105 (2003).
2. Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J., Lancet, 367, 1747-1757 (2006).
3. Carroll B. J., Curtis G. C., Mendels J., Arch. Gen. Psychiatry, 33, 1051-1058 (1976).
4. Carpenter W. T., Bunney W. E. Jr., Am. J. Psychiatry, 128, 31-40 (1971).
5. Carroll B. J., Feinberg M., Greden J. F., Tarika J., Albala A. A., Haskett R. F., James N. M., Kronfol Z., Lohr N., Steiner M., de Vigne J. P., Young E., Arch. Gen. Psychiatry, 38, 15-22 (1981).
6. Kelly W. F., Checkley S. A., Bender D. A., Br. J. Psychiatry, 136, 125-132 (1980).
7. Murphy B. E. P., Dhar V., Ghadirian A. M., Chouinard G., Keller R., J. Clin. Psychopharmacol., 11, 121-126 (1991).
8. Sonino N., Boscaro M., Ambroso G., Merola G., Mantero F., IRCS J. Med. Sci., 14, 485-486 (1986).
9. Wolkowitz O. M., Reus V. I., Manfred F., Ingbar J., Brizendine L., Weingartner H., Am. J. Psychiatry, 150, 810-812 (1993).
10. Murphy B. E. P., Filipini D., Ghadirian A. M., J. Psychiatr. Neurosci., 18, 209-213 (1993).
11. Kitamura Y., Araki H., Gomita Y., Pharmacol. Biochem. Behav., 71, 63-69 (2002).
12. Fuchs E., Czeh B., Flugge G., Behav. Pharmacol., 15, 315-325 (2004).
13. Malberg J. E., Duman R. S., Neuropsychopharmacology, 28, 1562-1571 (2003).
14. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R., Science, 301, 805-809 (2003).
15. Kodama M., Fujioka T., Duman R. S., Biol. Psychiatry, 56, 570-580 (2004).
16. Doi M., Miyazaki I., Nagamachi T., Shinomiya K., Matsunaga H., Sendo T., Kawasaki H., Asanuma M., Gomita Y., Kitamura Y., Acta Med. Okayama, 64, 219-223 (2010).
17. Oomen C. A., Mayer J. L., de Kloet E. R., Joëls M., Lucassen P. J., Eur. J. Neurosci., 26, 3395-3401 (2007).
18. Dayer A. G., Ford A. A., Cleaver K. M., Yassaee M., Cameron H. A., J. Comp. Neurol., 460, 563-572 (2003).
19. Cameron H. A., Woolley C. S., McEwen B. S., Gould E., Neuroscience, 56, 337-344 (1993).
20. Gould E., Beylin A., Tanapat P., Reeves A., Shors T. J., Nat. Neurosci., 2, 260-265 (1999).
21. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R., Science, 301, 805-809 (2003).
22. Kodama M., Fujioka T., Duman R. S., Biol. Psychiatry, 56, 570-580 (2004).
23. Malberg J. E., Eisch A. J., Nestler E. J., Duman R. S., J. Neurosci., 20, 9104-9110 (2000).
24. Ghoshdastidar D., Poddar M. K., Indian J. Exp. Biol., 28, 444-450 (1990).
25. Hotta I., Yamawaki S., Neuropharmacology, 27, 987-992 (1998).
26. Kitamura Y., Araki H., Suemaru K., Gomita Y., Pharmacol. Biochem. Behav., 72, 397-402 (2002).
27. Jha S., Rajendran R., Fernandes K. A., Vaidya V. A., Neurosci. Lett., 441, 210-214 (2008).
28. Alonso R., Griebel G., Pavone G., Stemmelin J., Mol. Psychiatry, 9, 278-286 (2004).
29. Malberg J. E., Eisch A. J., Nestler E. J., Duman R. S., J. Neurosci., 20, 9104-9119 (2000).